Karen McLean

10PUBLICATIONS
43CO-AUTHORS
Molecular targetsEpidemiological methodsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Feb 13, 2025
Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222.

Adam P Dommer, Vishnu Kumarasamy, Jianxin Wang

|Feb 09, 2025
Discrete vulnerability to pharmacological CDK2 inhibition is governed by heterogeneity of the cancer cell cycle.

Vishnu Kumarasamy, Jianxin Wang, Michelle Roti

|Jun 06, 2023
A comparative study on behavior, awareness and belief about cervical cancer among rural and urban women in Vietnam.

Minh Tung Phung, Pham Le An, Nguyen Nhu Vinh

|Oct 14, 2022
The "Sweet Spot" of Targeting Tumor Metabolism in Ovarian Cancers.

Katelyn Tondo-Steele, Karen McLean

|Nov 18, 2021
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.

Katharine K Brieger, Minh Tung Phung, Bhramar Mukherjee

Pageof 2